At least one drug maker sanctioned earlier this month by the European Commission for pay-for-delay agreements has appealed the sanction, according to reports.
Pharmaceutical firm Mylan, which owns Matrix laboratories – one of the companies fined by the Commission – will challenge the fines that were imposed after the Commission found …read more
Source: Global Competition Law Blogs